Testing effectiveness (Phase 2)Study completedNCT02170064What this trial is testingPharmacokinetics, Efficacy and Tolerability of BIA 2-093Who this might be right forEpilepsy Bial - Portela C S.A. 35
Large-scale testing (Phase 3)WithdrawnNCT03108729What this trial is testingA Pediatric Drug Study to Determine the Long-term Safety and Tolerability in Children and Adolescents (4-17 Years in Age) Taking the DrugWho this might be right forEpilepsy Sumitomo Pharma America, Inc.
Large-scale testing (Phase 3)Study completedNCT00988156What this trial is testingEslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in ChildrenWho this might be right forPartial Epilepsy in Children and Adolescents Bial - Portela C S.A. 304
Large-scale testing (Phase 3)Study completedNCT01364597What this trial is testingOpen-label Long-term Study of Adjunctive Brivaracetam in Pediatric Subjects With EpilepsyWho this might be right forEpilepsy UCB Pharma SA 257